We have isolated several mutant herpes simplex viruses, specifically mutated in the infected cell protein 8 (ICP8) gene, to define the functional domains of ICP8, the major viral DNA-binding protein. To facilitate the isolation of these mutants, we first isolated a mutant virus, HD-2, with the lacZ gene fused to the ICP8 gene so that an ICP8-40-galactosidase fusion protein was expressed. This virus formed blue plaques on ICP8-expressing cell lines in the presence of 5-bromo-4-chloro-3-indolyl-,1-D-galactopyranoside. Mutated ICP8 gene plasmids contransfected with HD-2 DNA yielded recombinant viruses with the mutant ICP8 gene incorporated into the viral genome. These recombinants were identified by formation of white plaques. Four classes of mutants were defined: (i) some expressed ICP8 that could bind to DNA but could not localize to the cell nucleus; (ii) some expressed ICP8 that did not bind to DNA but localized to the nucleus; (iii) some expressed ICP8 that neither bound to DNA nor localized to the nucleus; and (iv) one expressed ICP8 that localized to the cell nucleus and bound to DNA in vitro, but the mutant virus did not replicate its DNA. These classes of mutants provide genetic evidence that DNA binding and nuclear localization are distinct functions of ICP8 and that ICP8 has nuclear functions other than binding to DNA. Furthermore, the portion of ICP8 needed for a nuclear function(s) distinct from DNA binding is the part of ICP8 showing sequence similarity to that of the cellular protein cyclin or proliferating cell nuclear antigen.
The major DNA-binding protein, or infected cell protein 8 (ICP8), is expressed by herpes simplex virus type 1 as a X or delayed early gene product. This gene product is required for viral DNA synthesis (7, 10, 29, 49, 51) and normal regulation of viral gene expression (16, 17) . The functions and activities specified by ICP8 have not been completely established. The known properties of ICP8 include (i) the ability to bind to DNA in vitro and in vivo, (ii) the ability to localize to the cell nucleus, and (iii) the ability to promote assembly of nuclear structures involving viral and cellular DNA replication proteins.
ICP8 binds to single-stranded (ss) or double-stranded DNA in vitro (2, 21, 37, 42) and can be isolated in deoxynucleoprotein complexes from infected cells (25, 26) . The latter observation has been interpreted to mean that ICP8 interacts directly with DNA in the infected cells. Because DNA binding by ICP8 molecules encoded by temperature-sensitive (ts) mutants is thermolabile in vivo (25, 26) or in vitro (42) , this property may be an essential function of ICP8. The portion of ICP8 involved in DNA binding has not been precisely mapped. Some of the alterations in ICP8 molecules that are thermolabile for DNA binding are at residues 119, 348, and 450 (15) . Because these sequence alterations render the protein conditionally defective, these changes may directly or indirectly affect the DNA binding site on ICP8. Leinbach and Heath (27) have reported that the carboxylterminal 69 kilodaltons of ICP8 can bind to DNA in vitro. Thus, the DNA-binding domain of ICP8 may map within this portion of the molecule, but a more precise mapping of this property is needed.
ICP8 contains the necessary signals for nuclear localization in the absence of other viral proteins (39) , but these signals have not been mapped. One mutant protein, lacking * Corresponding author. residues 326 to 584, fails to localize to the nucleus (34), but it is not known whether the defect is due to lack of an essential localization signal or an altered conformation preventing nuclear uptake.
Cell biological studies of ICP8 nuclear localization have shown that ICP8 localizes to infected cell structures called prereplicative sites in the absence of viral DNA replication (12, 39) . In these structures, ICP8 behaves as if it were bound to the nuclear matrix. Viruses expressing an altered ICP8 molecule fail to assemble prereplicative sites, and from these results, we concluded that ICP8 promotes the assembly of these structures containing DNA replication proteins (12) . The portion(s) of ICP8 needed to promote assembly of prereplicative sites has not been identified.
To identify the portion of ICP8 needed for these functions and to attempt to separate the various functions of ICP8, we have devised a genetic system for the efficient transfer of mutations to the ICP8 gene in the viral genome. This report outlines the initial characterization of a set of viruses containing mutations specifically introduced into the ICP8 gene. The phenotypes of these viruses indicate that DNA binding and nuclear localization are genetically independent functions of ICP8 and that ICP8 specifies nuclear functions in addition to DNA binding.
MATERIALS AND METHODS
Cells and viruses. Vero cells were grown and maintained as described previously (23) . The growth medium for the Neor cell lines S2 and B10 (see below) included 200 ,ug of the antibiotic G418 per ml during the first passage of cells after thawing or 500 pg of G418 per ml every five passages.
The herpes simplex virus type 1 wild-type strain KOS1.1 was propagated and assayed as described previously (23, 25) . Mutant viruses were grown in ICP8-expressing S2 and (25, 40) or p8B-S (15) and pSVneo (45) essentially as described by Deluca et al. (13) . After growth in medium containing the antibiotic G418 (a neomycin analog), 21 drug-resistant colonies were picked, grown into cultures, and screened for their ability to complement the growth of the ICP8 mutants tsl3, tsl8, and tsHAl (10, 20) . At the nonpermissive temperature, these ts mutants formed plaques in 7 of 21 cell lines derived from cultures receiving the ICP8 gene but not efficiently in Neor cells which were derived from cultures transfected with plasmid pSV2neo alone. The cell clone B10, derived from a culture transfected with plasmid p8B-S, and S2 cells, derived from a culture transfected with pSG18-SacI, yielded the highest levels of complementation and were chosen for further use (Table 1) . KOS1.1 formed plaques in Neor cells as well as in B10 and S2 cells at both temperatures. The mutant viruses tsl3, tsl8, and tsHAl formed plaques efficiently only at 33.5°C in Neor cells but formed plaques at the wild-type level at both temperatures in B10 and S2 cells. Southern blot hybridization was performed to determine the copy number of the ICP8 gene in these cell lines, and B10 and S2 cells contained approximately 1 and 10 copies per haploid genome, respectively (data not shown).
Plasmids. Plasmids p8B-S, pSV8, and pml, as well as the nucleotide numbering system, were described previously (15, 47) . The plasmid p8B-S was constructed by cloning a 5.9-kilobase-pair (kbp) BamHI-SacI fragment (map units 0.374 to 0.411), including the ICP8 gene promoter, into pUC18. The plasmid pSV8 was constructed by inserting a 5.5-kbp SmaI-Sacl fragment (map units 0.374 to 0.409) downstream of the simian virus 40 early promoter, and the plasmid pml was derived from plasmid pSV8 by changing codons 499 and 502 of the ICP8 gene from cysteine codons to glycine codons. Mutant ICP8 gene plasmids used in this study were derived from pICP8 or pSPICP8, in which a 5.5 kbp SmaI-Sacl fragment (map units 0.374 to 0.409) was inserted into pUC19 or pSP64, respectively. Plasmids pnlO and pn2 were generated by linearization of the plasmid spICP8 (which was achieved by partial digestion with SmaI) and subsequent insertion of a 14-nucleotide (nt) XbaI linker (5'-CTAGTCTAGACTAG-3'; New England BioLabs, Inc., Beverly, Mass.) containing stop codons in all three reading frames at nts 4084 and 3695, respectively. Therefore, pnlO encodes the first 1,160 amino acid residues, and pn2 encodes the first 1,029 amino acid residues of ICP8 as well as 4 additional amino acids, Pro-Ser-Leu-Asp, encoded Isolation of mutant viruses. The mutant virus HD-2, containing a lacZ insertion in the ICP8 gene, was isolated by the following steps. After deletion of a 780-bp XhoI fragment from plasmid pICP8, the plasmid was briefly digested with BAL 31, a BglII linker was added, and the lacZ gene (Pharmacia, Inc., Piscataway, N.J.) was inserted. The lacZ gene of pMC1871 contains no transcription promoter and lacks the first eight nonessential amino-terminal codons. The mixture of ICP8:lacZ plasmids was transfected with KOS1.1 DNA into B10 cells (22) . After infection with the progeny virus, B10 or S2 cells were overlaid with medium 199: 1% calf serum containing 0.1% human immune serum for 1 to 2 days at 37°C. To detect P-galactosidase activity, the medium was then changed to 199 medium: 1.0% agarose containing 400 ,ug of 5-bromo-4-chloro-3-indolyl-(3-D-galactopyranoside (X-Gal) per ml for 8 to 16 h. Recombinant viruses were identified as blue plaques at a frequency of about 0.1 to 0.5%. One mutant virus was plaque purified and designated as HD-2.
HD-2 served as the recipient virus to generate all mutant viruses in this study except d301. After cotransfection of infectious HD-2 DNA with mutated ICP8 plasmids, the potential recombinant viruses were first isolated as white plaques from the population of parental blue plaques in the presence of X-Gal and then selected for further analysis.
The mutant virus d301 was constructed by cotransfection of B10 cells with infectious KOS1.1 DNA and plasmid pd301, in which a 2,001-bp NotI fragment was deleted from the ICP8 coding sequence (Fig. 1) . The progeny viruses from the marker transfer were tested for their ability to grow in B10 cells but not in Vero cells. One of the more then 300 viruses tested could grow in B10 but not in Vero cells.
Analysis of viral proteins. Cell monolayer cultures were infected with KOS1.1 or mutant virus and then labeled with [35S]methionine and harvested as indicated in the text. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of infected-cell lysates was performed as described previously (23) . After electrophoresis, gels were fixed, dried, and exposed to Kodak SB5 film, or the proteins were transferred by electrophoresis (30 V, 0.2 A overnight) to nitrocellulose filters for Western blot analysis. Detection of immune complexes on blots by a Western blot procedure involving a color reaction for the alkaline phosphatase activity was conducted as specified by the manufacturers (Promega Biotec, Madison, Wis.). The rabbit polyclonal serum 3-83 (24) or the mouse monoclonal antibody lOE-3 (41) (diluted 1:400) was used to detect ICP8. We used a densitometer to scan the (Fig. 3, lane 2) . Comparisons of Kpnl digests of KOS1.1 (Fig. 3, lane 4 Growth properties. All mutant viruses containing the mutations described in Fig. 1 (Fig. 4) . The sizes of the ICP8 polypeptides specified by the mutant viruses were consistent with the expected mutational alterations. The lOE-3 mouse monoclonal antibody reacted with ICP8 polypeptides of mutants pml, dlOl, d102, and d301 ( b The antibody used for the Western blots to visualize ICP8 was rabbit polyclonal (24) or mouse monoclonal 1OE-3 (41 [5 ,ug] and lane 4 [1 pLg]) was digested with BamHI and XhoI and separated by agarose gel electrophoresis. After electrophoresis, the gel was treated with 1.0 M sodium salicylate for fluorography.
DNA was loaded (Fig. 5, lane 4) . Therefore, we conclude that the viral mutants synthesized levels of viral DNA less than 10% of the wild-type level of DNA. In the mockinfected samples (Fig. 5, lane 1) , a band of host DNA was seen. Thus, in mutant-infected cells, viruses could not promote viral DNA synthesis, but they still had the ability to inhibit incorporation of [3H]thymidine into cellular DNA by 6 h postinfection.
DNA-binding properties of ICP8. (i) Solublity. Prior to studying the DNA-binding properties of mutant ICP8 molecules, the solubilities of the ICP8 polypeptides under standard extraction conditions were examined ( Table 2 ). The solubility of the altered ICP8 polypeptides varied significantly. For example, nlO ICP8 was just as soluble as was wild-type ICP8, but for n2 and pml, only approximately 10% was soluble.
(ii) Ability to bind to DNA. The DNA-binding properties of the soluble fraction of ICP8 molecules encoded by the mutant viruses were examined by chromatography on ss-DNA-cellulose columns. Because of the insolubility of some mutant ICP8 polypeptides, all extracts were clarified by centrifugation before application to the columns. The soluble fraction of the extracts was applied to the columns, and the proteins were eluted with increasing NaCl concentrations. Figure 6 shows the results for KOS1.1 and pml ICP8. Almost all of KOS1.1 ICP8 bound to the column (compare lanes 4 and 5 in Fig. 6A) , and the majority of bound ICP8 was eluted at 0.5 M NaCl (lane 12). In contrast, the majority of pml ICP8 came out in the flowthrough (compare lanes 4 and 5 in Fig. 6B ). The amount of each form of ICP8 eluted at each of the different NaCl concentrations from ssDNA cellulose columns was determined (Table 3) . Mutant nlO ICP8 bound to ssDNA-cellulose as efficiently and tightly as did wild-type ICP8. The lowest level of binding was observed with d301 ICP8 (21%) in which 56% of ICP8 was missing. The majority of the ICP8 encoded by amino, terminal deletion mutants dlOl and d102 bound to DNA cellulose (72 and 75%, respectively). In contrast, the majority of n2 ICP8 was found in the flowthrough and wash fractions (54%). This result is consistent with the results of Leinbach and Heath (27) in which the carboxyl-terminal region, but not the amino-terminal region, of ICP8 synthesized in vitro bound to ssDNA cellulose columns. Therefore, we conclude that the portion of ICP8 from residues 564 to 1160 contains a region required for DNA binding.
Nuclear localization of ICP8 molecules encoded by viral mutants. Wild-type ICP8 was previously shown by immunofluorescence microscopy to localize into the nucleus in infected cells (14, 23, 38, 39) . In the presence of a DNA synthesis inhibitor, ICP8 was found at the prereplicative sites ( Fig. 7B ; [39] ) and during viral DNA replication, ICP8 was distributed in the nucleus as replication compartments (39) . The cellular distribution of wild-type and mutant ICP8 molecules is shown in Fig. 7 . The nlO ICP8 polypeptide, which lacks the last 36 amino acids from the carboxyl terminus and bound to an ssDNA cellulose column just as tightly as wild-type ICP8, remained within the cytoplasm (Fig. 7C) . In contrast, the pml ICP8 polypeptide, which bound poorly to an ssDNA-cellulose column, was found predominantly in the nucleus (Fig. 7E) . These results clearly demonstrate that the nucleus localization signal(s) of ICP8 is separate from the DNA-binding function.
The dlOl ICP8 localized primarily within the nucleus (Fig.  7H ) and bound to an ssDNA cellulose column ( the group A mutants could be attributed to the fact that ICP8 was excluded from the nucleus. However, we do not know whether restoration of nuclear localization would be sufficient for normal function of the protein. The group D mutant dlOl exhibits a novel phenotype because it localized predominantly to the nucleus (Fig. 7H) , and the majority of it can bind to ssDNA in vitro, but the mutant virus still fails to replicate viral DNA. This indicates that the role of ICP8 in viral DNA replication must be more than just simply binding to ssDNA. Matsumoto et al. (32) observed that the aminoterminal one-fifth of ICP8 shares some sequence similarity with rat proliferating cell nuclear antigen (PCNA), also known as cyclin (3) or the DNA polymerase-delta auxiliary protein (48) . PCNA is a highly conserved protein whose synthesis is tightly associated with the cell cycle, occurring immediately before DNA synthesis (5, 30) . PCNA, like ICP8, is a nuclear protein, and the intranuclear distribution of both PCNA and ICP8 is controlled by DNA synthesis itself or events triggered by DNA replication (5, 39). Moreover, the sites of nuclear localization of both PCNA and ICP8 have been found to correspond to sites of ongoing DNA synthesis (12, 31) . In addition, both PCNA and ICP8 are required for DNA synthesis and can stimulate the activity of DNA polymerase (4, 33, 43, 48) . Because the group D mutant virus dlOl lacks the amino terminus of ICP8, it is conceivable that the amino terminus of ICP8 or a portion of it, like PCNA, has some nuclear function(s). This function(s) may involve interactions with different structural or functional elements in the infected cell nucleus, e.g., interaction with and stimulation of DNA polymerase (9) .
The region required for DNA binding. In this study, mutant nlO ICP8 molecules bound to ssDNA in vitro as tightly and efficiently as wild-type ICP8 molecules did but failed to localize to the nucleus, suggesting that the absence of 36 carboxyl-terminal amino acids of ICP8 only affected nuclear localization, not DNA binding. This is in agreement with our previous finding that the abilities of ICP8 to localize to the nucleus and bind to the nuclear matrix are distinct from DNA-binding ability (25) . Significant quantitative differences in DNA binding were observed when ICP8 was further truncated to residue 1029 (n2, 46%, compared with 98% for nlO polypeptide [ Table 3 ]). This indicates that the region between residues 1029 and 1260 of ICP8 is required for efficient DNA binding. In addition, approximately 72 and 75% of dlOl and d102 ICP8 polypeptides bound to ssDNA cellulose columns, respectively (Table 3 ). This demonstrated that the region from residues 564 to 1160 contains an ssDNA binding site. It should be noted that the majority of mutant ICP8 molecules which bound to ssDNA-cellulose eluted from the columns at a lower salt concentration (0.3 M NaCl) than that of wild-type ICP8 (0.5 M NaCl), suggesting that the amino terminus of ICP8 may be required for tight and efficient binding.
The mapping of the ssDNA binding domain of ICP8 must take into account not only the phenotypes of the deletion mutants but also the phenotypes of the ts mutants (15) . Several interpretations of these results are possible. First, the amino-terminal portion of ICP8 is not absolutely required for ssDNA binding but may be involved in stabilizing the binding activity of the carboxyl terminus. This could explain the failure of the ICP8 molecules of tsl3, tsl8, and tsHAl at the nonpermissive temperature to bind to DNA. Second, the amino terminus of ICP8 may be involved in the interactions with the carboxyl terminus of another molecule of ICP8, thus providing cooperative ssDNA binding. This is supported by the fact that mutant ICP8 polypeptides of dlOl and d102 did not bind ssDNA-cellulose columns as efficiently as wild-type ICP8. It is also possible that ICP8 contains not only multiple binding sites but also an inhibitory region which could modulate the DNA-binding activities of this polypeptide.
It is interesting to note that the pml ICP8 polypeptide bound poorly to the ssDNA-cellulose column (31% binding [ Table 3 ]), while the dlOl polypeptide, which is missing the zinc finger structure motif (Cys-X2-4-Cys-X2-15-His-X2-4-His), bound relatively well (72% binding). A similar observation was made for the DNA-binding domain of the simian virus 40 T antigen (1). Thus, this putative zinc finger cannot be an essential determinant of DNA binding for ICP8; however, it may still be involved in modulating the DNAbinding activity. It will be interesting to examine ssDNAbinding activities of ICP8 when either of these cysteines or adjacent cysteines are changed. Complete deletion of this region may lead the truncated dlOl polypeptide to fold differently, allowing the binding region access to ssDNA.
The results of this study demonstrate that the nuclear localization signal(s) and ssDNA-binding domain(s) of ICP8 are separable. Analysis of these and additional ICP8 mutants will provide a more detailed definition of the ssDNA-binding domain(s) and its role in viral DNA replication and the nature of the other nuclear functions of ICP8.
